2H04 - Header Asymmetric Unit

HEADER HYDROLASE 13-MAY-06 2H04

TITLE STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA TITLE 2 CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, B,; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 1662-1973; COMPND 5 EC: 3.1.3.48; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPRB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TOP10; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDEST-HISMBP

KEYWDS PROTEIN TYROSINE PHOSPHATASE, WPD-LOOP, SULFAMIC ACID, KEYWDS 2 PHOSPHATASE, INHIBITOR, DRUG DESIGN, HYDROLASE

EXPDTA X-RAY DIFFRACTION

AUTHOR A.G.EVDOKIMOV,M.E.POKROSS,R.L.WALTER,M.MEKEL,J.L.GRAY, AUTHOR 2 K.G.PETERS,M.B.MAIER,K.D.AMARASINGHE,C.M.CLARK,R.NICHOLS

REVDAT 4 24-FEB-09 2H04 1 VERSN REVDAT 3 12-SEP-06 2H04 1 JRNL REVDAT 2 08-AUG-06 2H04 1 JRNL REVDAT 1 13-JUN-06 2H04 0

JRNL AUTH K.K.AMARASINGHE,A.G.EVDOKIMOV,K.XU,C.M.CLARK, JRNL AUTH 2 M.B.MAIER,A.SRIVASTAVA,A.O.COLSON,G.S.GERWE, JRNL AUTH 3 G.E.STAKE,B.W.HOWARD,M.E.POKROSS,J.L.GRAY, JRNL AUTH 4 K.G.PETERS JRNL TITL DESIGN AND SYNTHESIS OF POTENT, NON-PEPTIDIC JRNL TITL 2 INHIBITORS OF HPTPBETA. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 4252 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16759857 JRNL DOI 10.1016/J.BMCL.2006.05.074

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 13207 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 649 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 899 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.1750 REMARK 3 BIN FREE R VALUE SET COUNT : 49 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2300 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : -0.23000 REMARK 3 B33 (A**2) : 0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.381 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.248 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.157 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.831 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2391 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3246 ; 2.155 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 281 ; 8.347 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 123 ;36.525 ;23.496 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 406 ;19.278 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;18.391 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 344 ; 0.145 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1843 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1078 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1589 ; 0.319 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 168 ; 0.193 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 35 ; 0.257 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.329 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1425 ; 1.702 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2276 ; 2.793 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1090 ; 4.613 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 968 ; 6.463 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2H04 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-06. REMARK 100 THE RCSB ID CODE IS RCSB037762.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13248 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 34.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.8800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.830 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1RPM (WITH MODIFICATIONS) REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21% PEG 8000, 220 MM MGCL2, 1% BME, REMARK 280 0.1% BOG, 5MM DTT, PH 8.0, VAPOR DIFFUSION, TEMPERATURE 298K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.40150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.36100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.06000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.36100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.40150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.06000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1661 REMARK 465 ASP A 1662 REMARK 465 ARG A 1663 REMARK 465 PRO A 1664 REMARK 465 LEU A 1665 REMARK 465 SER A 1666 REMARK 465 VAL A 1667 REMARK 465 HIS A 1668 REMARK 465 LEU A 1669 REMARK 465 ASN A 1670 REMARK 465 LEU A 1671 REMARK 465 GLY A 1672 REMARK 465 GLN A 1673 REMARK 465 LYS A 1674 REMARK 465 GLY A 1675 REMARK 465 ASN A 1676 REMARK 465 ARG A 1677 REMARK 465 VAL A 1749 REMARK 465 ASP A 1750 REMARK 465 ASP A 1751 REMARK 465 ASP A 1752 REMARK 465 PRO A 1753 REMARK 465 CYS A 1754 REMARK 465 GLU A 1852 REMARK 465 GLN A 1853 REMARK 465 LEU A 1854 REMARK 465 ASP A 1855 REMARK 465 ALA A 1856 REMARK 465 LEU A 1969 REMARK 465 ARG A 1970 REMARK 465 SER A 1971 REMARK 465 GLU A 1972 REMARK 465 GLN A 1973

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 1951 O HOH A 139 2.09 REMARK 500 SG CYS A 1804 O HOH A 63 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 1769 O HOH A 43 4555 1.68 REMARK 500 NE ARG A 1769 O HOH A 43 4555 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A1719 CB CYS A1719 SG 0.121 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A1719 CA - CB - SG ANGL. DEV. = 18.4 DEGREES REMARK 500 ARG A1732 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A1732 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A1726 -49.58 -24.45 REMARK 500 ARG A1770 64.19 -119.05 REMARK 500 ASP A1819 -166.89 -165.82 REMARK 500 HIS A1871 14.10 56.03 REMARK 500 SER A1894 76.83 -118.37 REMARK 500 CYS A1904 -125.86 -133.14 REMARK 500 VAL A1908 -52.55 -131.82 REMARK 500 ASP A1928 -10.60 -46.81 REMARK 500 SER A1929 144.71 -172.59 REMARK 500 VAL A1947 91.01 65.94 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4UN A 401

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HO2 RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA REMARK 900 CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS REMARK 900 RELATED ID: 2HO3 RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA REMARK 900 CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS

DBREF 2H04 A 1662 1973 UNP Q3MIV7 Q3MIV7_HUMAN 1662 1973

SEQRES 1 A 313 SER ASP ARG PRO LEU SER VAL HIS LEU ASN LEU GLY GLN SEQRES 2 A 313 LYS GLY ASN ARG LYS THR SER CYS PRO ILE LYS ILE ASN SEQRES 3 A 313 GLN PHE GLU GLY HIS PHE MET LYS LEU GLN ALA ASP SER SEQRES 4 A 313 ASN TYR LEU LEU SER LYS GLU TYR GLU GLU LEU LYS ASP SEQRES 5 A 313 VAL GLY ARG ASN GLN SER CYS ASP ILE ALA LEU LEU PRO SEQRES 6 A 313 GLU ASN ARG GLY LYS ASN ARG TYR ASN ASN ILE LEU PRO SEQRES 7 A 313 TYR ASP ALA THR ARG VAL LYS LEU SER ASN VAL ASP ASP SEQRES 8 A 313 ASP PRO CYS SER ASP TYR ILE ASN ALA SER TYR ILE PRO SEQRES 9 A 313 GLY ASN ASN PHE ARG ARG GLU TYR ILE VAL THR GLN GLY SEQRES 10 A 313 PRO LEU PRO GLY THR LYS ASP ASP PHE TRP LYS MET VAL SEQRES 11 A 313 TRP GLU GLN ASN VAL HIS ASN ILE VAL MET VAL THR GLN SEQRES 12 A 313 CYS VAL GLU LYS GLY ARG VAL LYS CYS ASP HIS TYR TRP SEQRES 13 A 313 PRO ALA ASP GLN ASP SER LEU TYR TYR GLY ASP LEU ILE SEQRES 14 A 313 LEU GLN MET LEU SER GLU SER VAL LEU PRO GLU TRP THR SEQRES 15 A 313 ILE ARG GLU PHE LYS ILE CYS GLY GLU GLU GLN LEU ASP SEQRES 16 A 313 ALA HIS ARG LEU ILE ARG HIS PHE HIS TYR THR VAL TRP SEQRES 17 A 313 PRO ASP HIS GLY VAL PRO GLU THR THR GLN SER LEU ILE SEQRES 18 A 313 GLN PHE VAL ARG THR VAL ARG ASP TYR ILE ASN ARG SER SEQRES 19 A 313 PRO GLY ALA GLY PRO THR VAL VAL HIS CYS SER ALA GLY SEQRES 20 A 313 VAL GLY ARG THR GLY THR PHE ILE ALA LEU ASP ARG ILE SEQRES 21 A 313 LEU GLN GLN LEU ASP SER LYS ASP SER VAL ASP ILE TYR SEQRES 22 A 313 GLY ALA VAL HIS ASP LEU ARG LEU HIS ARG VAL HIS MET SEQRES 23 A 313 VAL GLN THR GLU CYS GLN TYR VAL TYR LEU HIS GLN CYS SEQRES 24 A 313 VAL ARG ASP VAL LEU ARG ALA ARG LYS LEU ARG SER GLU SEQRES 25 A 313 GLN

HET 4UN A 401 32

HETNAM 4UN {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3- HETNAM 2 4UN PHENYLPROPYL]PHENYL}SULFAMIC ACID

FORMUL 2 4UN C21 H21 N5 O5 S FORMUL 3 HOH *141(H2 O)

HELIX 1 1 GLN A 1687 GLN A 1696 1 10 HELIX 2 2 GLN A 1696 LEU A 1710 1 15 HELIX 3 3 LEU A 1724 ASN A 1731 5 8 HELIX 4 4 THR A 1782 GLN A 1793 1 12 HELIX 5 5 THR A 1876 ARG A 1893 1 18 HELIX 6 6 VAL A 1908 LEU A 1924 1 17 HELIX 7 7 ASP A 1931 ARG A 1943 1 13 HELIX 8 8 THR A 1949 LYS A 1968 1 20

SHEET 1 A 2 ILE A1683 LYS A1684 0 SHEET 2 A 2 SER A1929 VAL A1930 -1 O VAL A1930 N ILE A1683 SHEET 1 B 9 ARG A1743 LYS A1745 0 SHEET 2 B 9 TYR A1757 ILE A1763 -1 O ALA A1760 N VAL A1744 SHEET 3 B 9 TYR A1772 THR A1775 -1 O VAL A1774 N SER A1761 SHEET 4 B 9 THR A1900 HIS A1903 1 O THR A1900 N ILE A1773 SHEET 5 B 9 ASN A1797 MET A1800 1 N VAL A1799 O VAL A1901 SHEET 6 B 9 ARG A1858 TYR A1865 1 O PHE A1863 N ILE A1798 SHEET 7 B 9 TRP A1841 CYS A1849 -1 N PHE A1846 O ILE A1860 SHEET 8 B 9 LEU A1828 VAL A1837 -1 N LEU A1833 O GLU A1845 SHEET 9 B 9 LEU A1823 TYR A1825 -1 N LEU A1823 O LEU A1830 SHEET 1 C 2 VAL A1805 GLU A1806 0 SHEET 2 C 2 ARG A1809 VAL A1810 -1 O ARG A1809 N GLU A1806

SITE 1 AC1 18 HOH A 15 TYR A1733 ASN A1734 ASN A1735 SITE 2 AC1 18 TYR A1824 ASP A1827 GLU A1851 ASP A1870 SITE 3 AC1 18 HIS A1871 CYS A1904 SER A1905 ALA A1906 SITE 4 AC1 18 GLY A1907 VAL A1908 GLY A1909 ARG A1910 SITE 5 AC1 18 HIS A1945 GLN A1948

CRYST1 44.803 70.120 90.722 90.00 90.00 90.00 P 21 21 21 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.022320 0.000000 0.000000 0.00000

SCALE2 0.000000 0.014261 0.000000 0.00000

SCALE3 0.000000 0.000000 0.011023 0.00000